✦ LIBER ✦

Evaluation of Model for End Stage Liver Disease (MELD)-based systems as prognostic index for hepatocellular carcinoma

✍ Scribed by Jenny L Limquiaco; Grace LH Wong; Vincent WS Wong; Paul BS Lai; Henry LY Chan

Book ID: 108952137
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 140 KB
Volume: 24
Category: Article
ISSN: 0815-9319
DOI: 10.1111/j.1440-1746.2008.05701.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Model for end-stage liver disease (MELD)

Model for end-stage liver disease (MELD) score, as a prognostic factor for post-operative morbidity and mortality in cirrhotic patients, undergoing hepatectomy for hepatocellular carcinoma

✍ Spiros G. Delis; Andreas Bakoyiannis; Ioannis Biliatis; Konstantinos Athanassiou 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 208 KB

Role of the model for end-stage liver di

Role of the model for end-stage liver disease and serum α-fetoprotein as prognostic predictors for hepatocellular carcinoma

✍ TEH-IA HUO; SHOU-DONG LEE 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 53 KB

Impact of model for end-stage liver dise

Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis

✍ Alessandro Cucchetti; Giorgio Ercolani; Marco Vivarelli; Matteo Cescon; Matteo R 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB 👁 1 views

The objective of this study was to predict postoperative liver failure and morbidity after hepatectomy for hepatocellular carcinoma (HCC) with cirrhosis. The model for end-stage liver disease (MELD) score is currently accepted as a disease severity index of cirrhotic patients awaiting liver transpla

Comparison of four model for end-stage l

Comparison of four model for end-stage liver disease–based prognostic systems for cirrhosis

✍ Teh-Ia Huo; Han-Chieh Lin; Samantha C. Huo; Pui-Ching Lee; Jaw-Ching Wu; Fa-Yauh 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 259 KB

Serum sodium (Na) has been suggested for incorporation into the Model for End-Stage Liver Disease (MELD) to enhance its prognostic ability for patients with cirrhosis. Three Na-containing models--the Model for End-Stage Liver Disease with the incorporation of serum sodium (MELD-Na), the integrated M

Liver transplantation for hepatocellular

Liver transplantation for hepatocellular carcinoma: Lessons from the first year under the Model of End-Stage Liver Disease (MELD) organ allocation policy

✍ Francis Y. Yao; Nathan M. Bass; Nancy L. Ascher; John P. Roberts 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 1 views

We examined the impact of the Model for End-Stage Liver Disease (MELD) organ allocation scheme on 44 patients with hepatocellular carcinoma (HCC) awaiting orthotopic liver transplantation (OLT) between February 2002 and January 2003, and compared the outcome with 58 patients listed in the 4 years be

Model for end-stage liver disease except

Model for end-stage liver disease exceptions in the context of the french model for end-stage liver disease score–based liver allocation system

✍ Claire Francoz; Jacques Belghiti; Denis Castaing; Olivier Chazouillères; Jean-Ch 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 437 KB 👁 1 views

Model for End-Stage Liver Disease (MELD) score-based allocation systems have been adopted by most countries in Europe and North America. Indeed, the MELD score is a robust marker of early mortality for patients with cirrhosis. Except for extreme values, high pretransplant MELD scores do not signific